MAPK3 and pancreatic ductal adenocarcinoma: Similarly, a recent study in pancreatic ductal adenocarcinoma (PDAC) has put forward that TPL2 enforced the activation of RAS-induced inflammatory signals to ensure constitutive ERK1/2 phosphorylation for tumor cell survival (Dodhiawala et al., 2020[10]).